ENPEP and breast cancer: Apart from the overexpression of ENPEP, CK2-α, CCNJ, and MEGF9 in certain breast cancer patients, the potential oncogenic roles of these proteins is supported by the fact that their downregulation causes significant inhibition of cell proliferation.